Quercetin Stabilizes Atherosclerotic Plaques by Reducing Matrix Metalloproteinase-9 Expression and Enhancing M2 Macrophage Activity in Wistar Rats
Abstract
BACKGROUND: Quercetin has been shown to alleviate and prevent atherosclerosis. However, its role in stabilizing atherosclerotic plaques to prevent plaque rupture remains unclear. Therefore, this study was conducted to investigate the effects of quercetin on stabilizing atherosclerotic plaques.
METHODS: Thirty-two Wistar rats were objected to a high-fat diet, along with an endothelial injury procedure conducted during the second week to create atherosclerotic plaque models. After six weeks, the subjects were randomly assigned to five groups consist of two control groups and three treatment groups treated with different quercetin dosages. Following the treatment, all subjects were euthanized to collect the left common carotid artery. The stability of the atherosclerotic plaques was evaluated by measuring the expression of matrix metalloproteinase-9 (MMP-9) using real-time polymerase chain reaction, assessing the activity of M1 and M2 macrophages along with the M1/M2 ratio using an enzyme-linked immunosorbent assay, and determining the maximum intima thickness through histopathological examination.
RESULTS: Quercetin significantly reduced the expression of MMP-9, increased the activity of M2 macrophages, and lowered the M1/M2 ratio at doses of 10 and 50 mg/kg. However, there was no effect on M1 macrophage activity or maximum intima thickness. Path analysis indicated that quercetin primarily enhanced atherosclerotic plaque stability by reducing MMP-9 expression (p<0.001) and subsequently enhancing M2 macrophage activity (p=0.002).
CONCLUSION: Quercetin administration significantly decreased the expression of MMP-9, enhanced the activity of M2 macrophages, and lowered the M1/M2 ratio at specific doses. These findings emphasize the significance of quercetin in stabilizing atherosclerotic plaques.
KEYWORDS: atherosclerotic plaque, quercetin, stability, Wistar rats
Full Text:
PDFReferences
Sakakura K, Nakano M, Otsuka F, Ladich E, Kolodgie FD, Virmani R. Pathophysiology of atherosclerosis plaque progression. Heart Lung Circ. 2013; 22(6): 399-411, CrossRef.
Sakamoto A, Cornelissen A, Sato Y, Mori M, Kawakami R, Kawai K, et al. Vulnerable plaque in patients with acute coronary syndrome: identification, importance, and management. US Cardiol. 2022; 16: e01, CrossRef.
Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014; 114(12): 1852-66, CrossRef.
Meiliana A, Wijaya A. Macrophage polarization in metabolism and metabolic disease. Indones Biomed J. 2013; 5(2): 81-90, CrossRef.
Roma-Lavisse C, Tagzirt M, Zawadzki C, Lorenzi R, Vincentelli A, Haulon S, et al. M1 and M2 macrophage proteolytic and angiogenic profile analysis in atherosclerotic patients reveals a distinctive profile in type 2 diabetes. Diabetes Vasc Dis Res. 2015; 12(4): 279-89, CrossRef.
Kamada C, da Silva EL, Ohnishi-Kameyama M, Moon JH, Terao J. Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit. Free Radic Res. 2005; 39(2): 185-94, CrossRef.
Rivera L, Morón R, Sánchez M, Zarzuelo A, Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity. 2008; 16(9): 2081-7, CrossRef.
Rusmana D, Wahyudianingsih R, Elisabeth M, Balqis B, Maesaroh M, Widowati W. Antioxidant activity of Phyllanthus niruri extract, Rutin and Quercetin. Indones Biomed J. 2017; 9(2): 84-90, CrossRef.
Panghiyangani R, Utami JP, Baitullah MA, Maulida ND. Molecular docking of Citrus amblycarpa active compounds against FTO, leptin, and resistin protein. Mol Cell Biomed Sci. 2023; 7(1): 38-46, CrossRef.
Luo G, Xiang L, Xiao L. Quercetin alleviates atherosclerosis by suppressing oxidized LDL-induced senescence in plaque macrophage via inhibiting the p38MAPK/p16 pathway. J Nutr Biochem. 2023; 116: 109314, CrossRef.
Kamada C, Mukai R, Kondo A, Sato S, Terao J. Effect of quercetin and its metabolite on caveolin-1 expression induced by oxidized LDL and lysophosphatidylcholine in endothelial cells. J Clin Biochem Nutr. 2016; 58(3): 193-201, CrossRef.
Golforoush P, Yellon DM, Davidson SM. Mouse models of atherosclerosis and their suitability for the study of myocardial infarction. Basic Res Cardiol. 2020; 115(6): 73, CrossRef.
Abdul Kadir NAA, Rahmat A, Jaafar HZE. Protective effects of Tamarillo (Cyphomandra betacee) extract against high fat diet induced obesity in Sprague-Dawley rats. J Obes. 2015; 2015: 846041, CrossRef.
Curaj A, Zhoujun W, Staudt M, Liehn EA. Induction of accelerated atherosclerosis in mice: The "wire-injury" model. JoVE. 2020; (162): 1-12, CrossRef.
Heryantho T, Wijaya A, Santoso T. Biochemical markers for determining vulnerable atherosclerotic plaque in stenotic patient: biochemical markers study of myeloperoxidase (MPO), matrix metallo-proteinase-9 (MMP-9), secretory phospholipase A2 (SPLA2) and CD40 ligand. Indones Biomed J. 2009; 1(2): 59-63, CrossRef.
Hong SY, Ha AW, Kim W. Effects of quercetin on cell differentiation and adipogenesis in 3T3-L1 adipocytes. Nutr Res Pract. 2021; 15(4): 444-55, CrossRef.
Song S, Ha AW, Kim W. Quercetin inhibits body weight gain and adipogenesis via matrix metalloproteinases in mice fed a high-fat diet. Nutr Res Pract. 2023; 17(3): 438-50, CrossRef.
Zhang L, Yang Z, Li X, Hua Y, Fan G, He F. Anti-atherosclerotic effects of naringenin and quercetin from Folium Artemisiae argyi by attenuating Interleukin-1 beta (IL-1β)/ matrix metalloproteinase 9 (MMP9): Network pharmacology-based analysis and validation. BMC Complement Med Ther. 2023; 23(1): 378, CrossRef.
Limanto A, Simamora A, Santoso AW, Timotius KH. Antioxidant, α-glucosidase inhibitory activity and molecular docking study of gallic acid, quercetin and rutin: a comparative study. Mol Cell Biomed Sci. 2019; 3(2): 67-74, CrossRef.
Hsieh HL, Yu MC, Cheng LC, Chu MY, Huang TH, Yeh TS, et al. Quercetin exerts anti-inflammatory effects via inhibiting tumor necrosis factor-α-induced matrix metalloproteinase-9 expression in normal human gastric epithelial cells. World J Gastroenterol. 2022; 28(11): 1139-58, CrossRef.
Li Y, Yao J, Han C, Yang J, Chaudhry M, Wang S, et al. Quercetin, inflammation and immunity. Nutrients. 2016; 8(3): 167, CrossRef.
Ben Geoffrey AS, Christian Prasana J, Muthu S. Structure-activity relationship of quercetin and its tumor necrosis factor alpha inhibition activity by computational and machine learning methods. Materials Today: Proceedings. 2022; 50: 2609-14, CrossRef.
Zhang J, Li H, Wang W, Li H. Assessing the anti‑inflammatory effects of quercetin using network pharmacology and in vitro experiments. Exp Ther Med. 2022; 23(4): 301, CrossRef.
Tsai CF, Chen GW, Chen YC, Shen CK, Lu DY, Yang LY, et al. Regulatory effects of quercetin on M1/M2 macrophage polarization and oxidative/antioxidative balance. Nutrients. 2021; 14(1): 67, CrossRef.
Otieno F. Immunometabolic processes of macrophages in disease states. In: Shamsadin Athari S, Mehrabi Nasab E, editors. Physiology. London: IntechOpen; 2023, CrossRef.
Peng J, Yang Z, Li H, Hao B, Cui D, Shang R, et al. Quercetin reprograms immunometabolism of macrophages via the SIRT1/PGC-1α signaling pathway to ameliorate lipopolysaccharide-induced oxidative damage. IJMS. 2023; 24(6): 5542, CrossRef.
Sallam AA, Ahmed MM, El-Magd MA, Magdy A, Ghamry HI, Alshahrani MY, et al. Quercetin-ameliorated, multi-walled carbon nanotubes-induced immunotoxic, inflammatory, and oxidative effects in mice. Molecules. 2022; 27(7): 2117, CrossRef.
Chen Y, Zhu L, Meng H, Sun X, Xue C. Ferulic acid protects human lens epithelial cells against ionizing radiation-induced oxidative damage by activating Nrf2/HO-1 signal pathway. Oxid Med Cell Longev. 2022; 2022: 6932188, CrossRef.
Shaban S, El-Husseny MWA, Abushouk AI, Salem AMA, Mamdouh M, Abdel-Daim MM. Effects of antioxidant supplements on the survival and differentiation of stem cells. Oxid Med Cell Longev. 2017; 2017: 5032102, CrossRef.
Li X, Jin Q, Yao Q, Xu B, Li L, Zhang S, et al. The flavonoid quercetin ameliorates liver inflammation and fibrosis by regulating hepatic macrophages activation and polarization in mice. Front Pharmacol. 2018; 9: 72, CrossRef.
An L, Zhai Q, Tao K, Xiong Y, Ou W, Yu Z, et al. Quercetin induces itaconic acid-mediated M1/M2 alveolar macrophages polarization in respiratory syncytial virus infection. Phytomedicine. 2024; 130: 155761, CrossRef.
Wang Y, Li C, Wan Y, Qi M, Chen Q, Sun Y, et al. Quercetin‐loaded Ceria nanocomposite potentiate dual‐directional immunoregulation via macrophage polarization against periodontal inflammation. Small. 2021; 17(41): 2101505, CrossRef.
Li T, Fu W, Li X, Huo Y, Ji H, Liang T, et al. Quercetin-loaded Melanin nanoparticles decorated with collagenase mediates synergistic immunomodulation and restores extracellular matrix homeostasis in liver fibrosis. ACS Appl Mater Interfaces. 2025; 17(1): 386-97, CrossRef.
Yang D, Sun C, Zhang J, Lin S, Zhao L, Wang L, et al. Proliferation of vascular smooth muscle cells under inflammation is regulated by NF-κB p65/microRNA-17/RB pathway activation. Int J Mol Med. 2017; 41: 43-50, CrossRef.
Chang X, Zhang T, Meng Q, ShiyuanWang, Yan P, Wang X, et al. Quercetin improves cardiomyocyte vulnerability to hypoxia by regulating SIRT1/TMBIM6-related mitophagy and endoplasmic reticulum stress. Oxid Med Cell Longev. 2021; 2021: 5529913, CrossRef.
Chis I, Coseriu A, Simedrea R, Oros A, Nagy A, Clichici S. In vivo effects of quercetin in association with moderate exercise training in improving streptozotocin-induced aortic tissue injuries. Molecules. 2015; 20(12): 21770-86, CrossRef.
Zaragozá C, Villaescusa L, Monserrat J, Zaragozá F, Álvarez-Mon M. Potential therapeutic anti-inflammatory and immunomodulatory effects of dihydroflavones, flavones, and flavonols. Molecules. 2020; 25(4): 1017, CrossRef.
Martinez-Campesino L, Kocsy K, Cañedo J, Johnston JM, Moss CE, Johnston SA, et al. Tribbles 3 deficiency promotes atherosclerotic fibrous cap thickening and macrophage-mediated extracellular matrix remodelling. Front Cardiovasc Med. 2022; 9: 948461, CrossRef.
Sugiyama T, Kanaji Y, Hoshino M, Hada M, Misawa T, Nagamine T, et al. Relationship of OCT-defined plaque characteristics with CCTA-derived coronary inflammation and CMR-derived global coronary flow reserve in patients with acute coronary syndrome. PLoS One. 2023; 18(5): e0286196, CrossRef.
Yao Y, Zhang P. Novel ultrasound techniques in the identification of vulnerable plaques-An updated review of the literature. Front Cardiovasc Med. 2023: 10: 1069745, CrossRef.
DOI: https://doi.org/10.18585/inabj.v17i5.3790
Copyright (c) 2025 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
